An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects

Summary

The purpose of this study is to assess the pharmacodynamic effects, pharmacokinetics, and safety of two oral formulations (tablet and capsule) of LX1033 in normal healthy volunteers.

Timeline

Start

2011-08

Primary completion

2011-10

Completion

2012-05

Drugs

Indications